The appointment of Heather Turner to the Board of Directors is likely to be viewed positively by investors as it brings significant strategic, operational, and legal expertise to Terns Pharmaceuticals. This could enhance the company's decision-making and strategic direction, potentially leading to positive short-term stock price movement.